Clinical Trial Update: Pioglitazone to Treat Fatty Liver in People With HIV Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pioglitazone for hepatic steatosis in people with HIV was completed, and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Insulin Resistance
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Hepatic Steatosis | Phase 2 | Status: COMPLETED | Results posted: 2010-02-19